Literature DB >> 1900145

Km typing with PCR: application to population screening.

J H Kurth1, A M Bowcock, H A Erlich, S Nevo, L L Cavalli-Sforza.   

Abstract

The immunoglobulin kappa light chain (IgK) locus may play a significant role in the pathology of both infectious and autoimmune diseases. Most of the work on IgK genetics has been conducted using immunological techniques for allelic typing and sequence analysis. This is restricted by availability of reagents and can be both expensive and time-consuming. PCR primers were designed to amplify the kappa constant gene (Ck), and four allele-specific oligonucleotides (ASOs) were used to distinguish the alleles in the amplified PCR products. Direct sequencing of PCR products was performed to confirm that the primers specifically amplified the Ck region and the ASOs differentiated the Km alleles. Sequencing of an average of 209 nucleotides of DNA from 50 individuals revealed no variation except at codon 191, which is known to be involved in a frequent polymorphism. An analysis of 347 different individual DNAs from 10 human populations was conducted to determine Km allelic frequencies within these populations and to apply this type of data collection to population studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900145      PMCID: PMC1682986     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Estimation of the coancestry coefficient: basis for a short-term genetic distance.

Authors:  J Reynolds; B S Weir; C C Cockerham
Journal:  Genetics       Date:  1983-11       Impact factor: 4.562

2.  Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals.

Authors:  P Hartl; M Lipp
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  A possible new genetic marker associated with a severe course of multiple sclerosis, located on chromosome 2: Km.

Authors:  C Berr; J M Dugoujon; M Clanet; A Cambon-Thomsen; A Alperovitch
Journal:  N Engl J Med       Date:  1989-02-16       Impact factor: 91.245

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes.

Authors:  R K Saiki; C A Chang; C H Levenson; T C Warren; C D Boehm; H H Kazazian; H A Erlich
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype.

Authors:  A A Lenoir; J P Pandey; D M Granoff
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

Review 7.  Molecular genetics of immunoglobulins.

Authors:  M J Taussig
Journal:  Immunol Suppl       Date:  1988

8.  DNA markers and genetic variation in the human species.

Authors:  L L Cavalli-Sforza; J R Kidd; K K Kidd; C Bucci; A M Bowcock; B S Hewlett; J S Freidlaender
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

Review 9.  Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature.

Authors:  C H Kijner; S A Yousem
Journal:  Am J Surg Pathol       Date:  1988-05       Impact factor: 6.394

10.  GM and INV factors in subclasses of human IgG.

Authors:  W D Terry; J L Fahley; A G Steinberg
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

View more
  3 in total

1.  Sequence-tagged-site-facilitated PCR for barley genome mapping.

Authors:  S Tragoonrung; V Kanazin; P M Hayes; T K Blake
Journal:  Theor Appl Genet       Date:  1992-09       Impact factor: 5.699

2.  Notes on individual sequence variation in humans: immunoglobulin kappa light chain.

Authors:  J H Kurth; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

3.  Light chain-associated amyloid deposits comprised of a novel kappa constant domain.

Authors:  A Solomon; D T Weiss; C L Murphy; R Hrncic; J S Wall; M Schell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.